Here are four takeaways:
1. Washington University School of Medicine researchers participated in clinical trials for new SCS devices, which deliver higher frequencies and cut down on tingling sensations.
2. Michael Bottros, MD, Barnes-Jewish Hospital assistant professor of anesthesiology and director of the acute pain service, told Medical Xpress that opioids help patients temporarily, but “new-generation stimulators fill an important niche.”
3. Studies have demonstrated SCS devices may prove more impactful for patients who underwent back surgery, but still experience pain.
4. Washington University Pain Management Center physicians see patients at the Center for Advanced Medicine.
More articles on devices:
Medtronic, DePuy Synthes & Stryker lead North American bone grafts & substitutes market — 7 observations
Medtronic announces $2B senior note offering priced: 5 things to know
Reprocessed medical device market to grow by 20% — 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
